Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?

JAMA. 2020 Mar 3;323(9):821-822. doi: 10.1001/jama.2019.22357.
No abstract available

MeSH terms

  • Anti-Retroviral Agents / economics
  • Anti-Retroviral Agents / supply & distribution*
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence*
  • Government Regulation
  • HIV Infections / prevention & control*
  • Health Services Accessibility / legislation & jurisprudence*
  • Humans
  • Legislation, Drug*
  • Patents as Topic / legislation & jurisprudence*
  • Pre-Exposure Prophylaxis / legislation & jurisprudence*

Substances

  • Anti-Retroviral Agents